FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012091857> ?p ?o ?g. }

• W2012091857 endingPage "17" @default.
• W2012091857 startingPage "11" @default.
• W2012091857 abstract "The semiautomated fluorimetric microculture cytotoxicity assay (FMCA) was used for evaluation of the ability of cyclosporin A (CsA) and its novel non-immunosuppressive derivative SDZ PSC 833 (PSC) to modify the response to doxorubicin or vincristine in vitro in different haematological and solid human tumour types. Primary cultures of 322 tumour samples were analysed. Both cyclosporins showed resistance-modifying activity in all haematological tumours tested, and in solid tumours activity was observed in ovarian carcinoma and childhood tumours. Little or no effect was found in the remaining tumour types, including breast, renal and adrenal cortical carcinomas and adult sarcomas. In most of the responsive cases the interaction between the modifier and the cytotoxic drug was synergistic. There was a tendency to higher activity in samples from previously treated patients, and an inverse relationship between degree of cytotoxic drug resistance and resistance-modifying activity was noted. No difference in potency between CsA and PSC could be discerned. The results indicate differential in vitro resistance-modifying activity of the cyclosporins depending on tumour type. The results also suggest that treatment with resistance modifiers should be considered also for primary therapy of drug-sensitive tumours. Drug resistance assays such as the FMCA may become useful in preclinical evaluation of resistance modifiers." @default.
• W2012091857 created "2016-06-24" @default.
• W2012091857 creator A5001084766 @default.
• W2012091857 creator A5002202838 @default.
• W2012091857 creator A5046486711 @default.
• W2012091857 creator A5062996283 @default.
• W2012091857 creator A5063856017 @default.
• W2012091857 creator A5070026603 @default.
• W2012091857 creator A5070357940 @default.
• W2012091857 creator A5076619769 @default.
• W2012091857 creator A5080988408 @default.
• W2012091857 creator A5081021047 @default.
• W2012091857 date "1994-07-01" @default.
• W2012091857 modified "2023-10-18" @default.
• W2012091857 title "Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours" @default.
• W2012091857 cites W1234770814 @default.
• W2012091857 cites W1536659233 @default.
• W2012091857 cites W1754065147 @default.
• W2012091857 cites W1776168062 @default.
• W2012091857 cites W1986222466 @default.
• W2012091857 cites W2003168739 @default.
• W2012091857 cites W2011373848 @default.
• W2012091857 cites W2012689911 @default.
• W2012091857 cites W2014480866 @default.
• W2012091857 cites W2017239698 @default.
• W2012091857 cites W2019670928 @default.
• W2012091857 cites W2024463580 @default.
• W2012091857 cites W2026703785 @default.
• W2012091857 cites W2036571761 @default.
• W2012091857 cites W2041209857 @default.
• W2012091857 cites W2057610786 @default.
• W2012091857 cites W2060358859 @default.
• W2012091857 cites W2065440699 @default.
• W2012091857 cites W2080347582 @default.
• W2012091857 cites W2088419541 @default.
• W2012091857 cites W2104733808 @default.
• W2012091857 cites W2146659244 @default.
• W2012091857 cites W2157876917 @default.
• W2012091857 cites W220750778 @default.
• W2012091857 cites W2228456847 @default.
• W2012091857 cites W2230711222 @default.
• W2012091857 cites W2276982989 @default.
• W2012091857 cites W2399918065 @default.
• W2012091857 cites W2411255792 @default.
• W2012091857 cites W2461647953 @default.
• W2012091857 cites W4290367724 @default.
• W2012091857 doi "https://doi.org/10.1038/bjc.1994.242" @default.
• W2012091857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2033318" @default.
• W2012091857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8018519" @default.
• W2012091857 hasPublicationYear "1994" @default.
• W2012091857 type Work @default.
• W2012091857 sameAs 2012091857 @default.
• W2012091857 citedByCount "25" @default.
• W2012091857 countsByYear W20120918572015 @default.
• W2012091857 crossrefType "journal-article" @default.
• W2012091857 hasAuthorship W2012091857A5001084766 @default.
• W2012091857 hasAuthorship W2012091857A5002202838 @default.
• W2012091857 hasAuthorship W2012091857A5046486711 @default.
• W2012091857 hasAuthorship W2012091857A5062996283 @default.
• W2012091857 hasAuthorship W2012091857A5063856017 @default.
• W2012091857 hasAuthorship W2012091857A5070026603 @default.
• W2012091857 hasAuthorship W2012091857A5070357940 @default.
• W2012091857 hasAuthorship W2012091857A5076619769 @default.
• W2012091857 hasAuthorship W2012091857A5080988408 @default.
• W2012091857 hasAuthorship W2012091857A5081021047 @default.
• W2012091857 hasBestOaLocation W20120918572 @default.
• W2012091857 hasConcept C109316439 @default.
• W2012091857 hasConcept C114851261 @default.
• W2012091857 hasConcept C126322002 @default.
• W2012091857 hasConcept C202751555 @default.
• W2012091857 hasConcept C2776535732 @default.
• W2012091857 hasConcept C2776694085 @default.
• W2012091857 hasConcept C2776755627 @default.
• W2012091857 hasConcept C2779429289 @default.
• W2012091857 hasConcept C2781303535 @default.
• W2012091857 hasConcept C2911091166 @default.
• W2012091857 hasConcept C49377226 @default.
• W2012091857 hasConcept C502942594 @default.
• W2012091857 hasConcept C55493867 @default.
• W2012091857 hasConcept C71924100 @default.
• W2012091857 hasConcept C86803240 @default.
• W2012091857 hasConcept C89423630 @default.
• W2012091857 hasConcept C98274493 @default.
• W2012091857 hasConceptScore W2012091857C109316439 @default.
• W2012091857 hasConceptScore W2012091857C114851261 @default.
• W2012091857 hasConceptScore W2012091857C126322002 @default.
• W2012091857 hasConceptScore W2012091857C202751555 @default.
• W2012091857 hasConceptScore W2012091857C2776535732 @default.
• W2012091857 hasConceptScore W2012091857C2776694085 @default.
• W2012091857 hasConceptScore W2012091857C2776755627 @default.
• W2012091857 hasConceptScore W2012091857C2779429289 @default.
• W2012091857 hasConceptScore W2012091857C2781303535 @default.
• W2012091857 hasConceptScore W2012091857C2911091166 @default.
• W2012091857 hasConceptScore W2012091857C49377226 @default.
• W2012091857 hasConceptScore W2012091857C502942594 @default.
• W2012091857 hasConceptScore W2012091857C55493867 @default.
• W2012091857 hasConceptScore W2012091857C71924100 @default.
• W2012091857 hasConceptScore W2012091857C86803240 @default.

• next